Reminder: Timelines of SOR Grant Period and Grant Years

We have recently received an influx of questions about the SOR grant period and grant year timelines and how the GPRA surveys fit into each, so we wanted to share a high-level breakdown to elaborate on these different time points.

 

Current SOR 3 Grant Period: October 1st, 2022 – September 30th, 2024

- SOR 3, Grant Year 1: October 1st, 2022 – September 30th, 2023

- SOR 3, Grant Year 2: October 1st, 2023 – September 30th, 2024

 

The Current SOR 3 Grant Period refers to the entire duration during which the SOR 3 grant is active, spanning from October 1st, 2022, to September 30th, 2024. Within this period, we have two grant years:

Grant Year 1: running from October 1st, 2022, to September 30th, 2023. This marks the initial year of the grant’s implementation in SOR 3. It is also the federal fiscal year of 2022-23.

Grant Year 2: following Grant Year 1, this period spans from October 1st, 2023, to September 30th, 2024, concluding the grant’s SOR 3 term. It is also the federal fiscal year of 2023-24.

Our intake and discharge GPRA guidelines during the grant period are:

  • Only one intake GPRA and one discharge GPRA should be completed for each client within the two-year grant period, not a single grant year.

  • If a client returns to services after having already completed an intake and discharge GPRA in the same 2-year grant period, they should not undergo another set of intake and discharge GPRAs.

As always, if you have any questions, please reach out to us at SORSupport@omni.org.

https://www.ecfr.gov/current/title-2/subtitle-A/chapter-II/part-200#200.112 Per 2 C.F.R. § 200.112-1113 The Federal awarding agency must establish conflict of interest policies for Federal awards. The non-Federal entity must disclose in writing any potential conflict of interest to the Federal awarding agency or pass-through entity in accordance with applicable Federal awarding agency policy. Failure to adhere to these statues will result in immediate termination of funding.

Virginia’s State Opioid Response (SOR) grant is awarded at the discretion of DBHDS and SAMHSA. All recipients of SOR funding supports evidence-based prevention, treatment and recovery services to address opioid and stimulant misuse and use disorders, including for cocaine and methamphetamine. The SOR grant is not intended to be utilized as a long-term or permanent funding source. All SOR proposals must include a realistic plan for financial sustainability beyond the grant period.